Piramal Pharma Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹2,139.87 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.70 per cent from ₹2,043.72 crore. This corresponds to a year-on-year *(YoY) decline of 2.92 per cent.
Operating Profit
Operating Profit stands at ₹142.74 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.33 per cent from ₹162.81 crore. This corresponds to a year-on-year *(YoY) growth of 7.74 per cent.
PBDT
PBDT stands at ₹255.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.32 per cent from ₹255.88 crore. This corresponds to a year-on-year *(YoY) decline of 1.87 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-93.86 crore, reflecting a quarter-on-quarter *(QoQ) increase of 103.25 per cent from ₹-46.18 crore. This corresponds to a year-on-year *(YoY) decline of 240.51 per cent.
Net Profit
Net Profit stands at ₹-95.08 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.17 per cent from ₹-99.22 crore. This represents a 2,683.70 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Piramal Pharma Ltd News
Piramal Pharma Ltd Earnings
- YOY
- QOQ
Piramal Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Piramal Pharma Ltd Research Reports
Piramal Pharma Ltd Financial Reports
Piramal Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Piramal Pharma | 0.75% | 1.38% | -8.89% | -23.21% | -18.78% | -32.61% |
| Wockhardt | 1.17% | 2.81% | -2.51% | -2.04% | -13.93% | -10.99% |
| Astrazeneca Phar | 2.65% | 2.78% | -2.33% | -12.67% | -3.60% | 15.21% |
| Pfizer | -0.98% | -1.11% | -7.39% | -12.01% | -9.81% | -0.01% |
| ERIS Lifescience | 2.24% | 2.37% | -8.30% | -13.89% | -23.79% | 11.16% |
| Sai Life | 0.86% | 1.82% | -7.22% | -9.44% | 6.31% | 27.38% |
| Neuland Labs. | 5.19% | 3.14% | -12.69% | -23.04% | 1.21% | -6.91% |
Company Info
Company Information
Chairperson : Nandini Piramal
Executive Director & CEO : PETER D DEYOUNG
Executive Director & CFO : Vivek Valsaraj
Non-Exec & Non-Independent Dir : Amit Jain
Independent Non Exe. Director : S Rama Dorai
Independent Non Exe. Director : Jairaj Manohar Purandare
Independent Non Exe. Director : Sridhar Gorthi
Independent Non Exe. Director : Peter Stevenson
Non-Exec & Non-Independent Dir : Nathalie Leitch
Independent Non Exe. Director : Vibha Paul Rishi
Company Sec. & Compli. Officer : Tanya Sanish